CMF
LLY icon

Counterpoint Mutual Funds’s Eli Lilly LLY Stock Holding History

Counterpoint Mutual Funds’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$759K Sell
633
-4,570
-88% -$4.67M 0.08% 110
2026
Q1 		$4.79M Buy
+5,203
New +$5.27M 0.72% 19
2024
Q4 		– Sell
-1,099
Closed -$974K – 351
2024
Q3 		$974K Buy
+1,099
New +$988K 0.18% 38

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Counterpoint Mutual Funds's LLY Position: Q2 2026 in Review

Counterpoint Mutual Funds reduced its Eli Lilly (LLY) stake by 88% in Q2 2026, selling an estimated $4.67M and leaving 633 shares worth $759K. The position accounts for 0.08% of the portfolio, ranked #110.

Counterpoint Mutual Funds first reported a position in LLY in Q3 2024 and has held it in 3 quarters since. The position peaked at $4.79M in Q1 2026. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Counterpoint Mutual Funds held 633 shares of Eli Lilly worth $759K as of Q2 2026.
  • Counterpoint Mutual Funds sold 4,570 Eli Lilly shares in Q2 2026, an estimated $4.67M.
  • Eli Lilly made up 0.08% of Counterpoint Mutual Funds's portfolio in Q2 2026, its #110 holding.
  • Counterpoint Mutual Funds first reported a position in Eli Lilly in Q3 2024 and has held it in 3 quarters since.
  • Counterpoint Mutual Funds's Eli Lilly position peaked at $4.79M in Q1 2026.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.